Aquisição de TISLELIZUMAB 10 MGML SOL INJ FR 10 ML IV 2026 - NOVO
TED · 558163-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Gaia/Espinho, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Medtronic Portugal, Lda. | 3 | €2,105,898 | 2026-08-10 |
| Abbott Medical Portugal | 3 | €1,664,440 | 2026-08-10 |
| Getinge Group Portugal | 2 | €890,420 | 2026-08-11 |
| LusoPalex - Produtos de Saúde Unipessoal Lda | 2 | €784,958 | 2026-08-11 |
| JOHNSON & JOHNSON, LDA | 2 | €588,396 | 2026-08-10 |
Full buyer profile: what Unidade Local de Saúde de Gaia/Espinho, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de TISLELIZUMAB 10 MGML SOL INJ FR 10 ML IV 2026 - NOVO
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-06 | 1363426 Aquisição de RISDIPLAM 5 MG COMP 2026 | Unidade Local de Saúde Gaia/Espinho, E.P.E. PT | 94% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-02 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-08-04 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-09 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |